California Public Employees Retirement System Has $21.35 Million Position in Hologic, Inc. (HOLX)

California Public Employees Retirement System lowered its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 0.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 581,795 shares of the medical equipment provider’s stock after selling 2,305 shares during the quarter. California Public Employees Retirement System owned approximately 0.21% of Hologic worth $21,346,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HOLX. Advisors Asset Management Inc. boosted its holdings in shares of Hologic by 7.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 16,602 shares of the medical equipment provider’s stock valued at $753,000 after purchasing an additional 1,140 shares during the last quarter. State of Wisconsin Investment Board boosted its holdings in shares of Hologic by 73.3% in the 2nd quarter. State of Wisconsin Investment Board now owns 249,267 shares of the medical equipment provider’s stock valued at $11,312,000 after purchasing an additional 105,430 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of Hologic by 6.5% in the 2nd quarter. Legal & General Group Plc now owns 1,377,892 shares of the medical equipment provider’s stock valued at $62,533,000 after purchasing an additional 84,516 shares during the last quarter. KBC Group NV boosted its holdings in shares of Hologic by 60.5% in the 2nd quarter. KBC Group NV now owns 34,855 shares of the medical equipment provider’s stock valued at $1,582,000 after purchasing an additional 13,138 shares during the last quarter. Finally, Jennison Associates LLC acquired a new position in shares of Hologic in the 2nd quarter valued at $454,000. Hedge funds and other institutional investors own 97.67% of the company’s stock.

In related news, Director Elaine Ullian sold 9,282 shares of Hologic stock in a transaction on Monday, November 13th. The shares were sold at an average price of $40.50, for a total transaction of $375,921.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Karleen Marie Oberton sold 1,023 shares of Hologic stock in a transaction on Monday, November 20th. The stock was sold at an average price of $39.84, for a total transaction of $40,756.32. The disclosure for this sale can be found here. Insiders have sold a total of 28,833 shares of company stock worth $1,107,270 in the last 90 days. Company insiders own 0.79% of the company’s stock.

A number of equities analysts have weighed in on the stock. Cowen upgraded shares of Hologic to a “buy” rating and set a $52.00 price target on the stock in a report on Wednesday. Piper Jaffray Companies reiterated a “buy” rating and issued a $48.00 price target on shares of Hologic in a report on Thursday, November 9th. Zacks Investment Research upgraded shares of Hologic from a “sell” rating to a “hold” rating in a report on Tuesday, October 31st. Royal Bank of Canada reiterated a “hold” rating and issued a $42.00 price target on shares of Hologic in a report on Friday, September 22nd. Finally, Jefferies Group reiterated a “buy” rating and issued a $44.00 price target (down previously from $49.00) on shares of Hologic in a report on Tuesday, October 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $47.93.

Hologic, Inc. (NASDAQ HOLX) opened at $43.44 on Thursday. The company has a current ratio of 0.79, a quick ratio of 0.61 and a debt-to-equity ratio of 0.79. The firm has a market cap of $11,989.48, a price-to-earnings ratio of 21.53, a P/E/G ratio of 2.10 and a beta of 0.95. Hologic, Inc. has a 1-year low of $35.76 and a 1-year high of $46.80.

Hologic (NASDAQ:HOLX) last posted its earnings results on Wednesday, November 8th. The medical equipment provider reported $0.50 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.01. The business had revenue of $802.90 million for the quarter, compared to analyst estimates of $792.54 million. Hologic had a net margin of 24.70% and a return on equity of 21.69%. The business’s quarterly revenue was up 10.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.52 EPS. research analysts forecast that Hologic, Inc. will post 2.12 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “California Public Employees Retirement System Has $21.35 Million Position in Hologic, Inc. (HOLX)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://sportsperspectives.com/2017/12/21/california-public-employees-retirement-system-has-21-35-million-position-in-hologic-inc-holx.html.

Hologic Profile

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply